## Abstract Tissue inhibitor of metalloproteinases‐4 (TIMP‐4), the newest member of the TIMP family, blocks the activities of several matrix metalloproteinases (MMPs) implicated in the arthritic cartilage erosion. By utilizing semi‐quantitative RT‐PCR, immunoblotting, and immunohistochemistry, we i
Tissue inhibitor of metalloproteinases 4 (TIMP4) is involved in inflammatory processes of human cardiovascular pathology
✍ Scribed by Ilpo Koskivirta; Otto Rahkonen; Mikko Mäyränpää; Sari Pakkanen; Michael Husheem; Annele Sainio; Harri Hakovirta; Jukka Laine; Eero Jokinen; Eero Vuorio; Petri Kovanen; Hannu Järveläinen
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 879 KB
- Volume
- 126
- Category
- Article
- ISSN
- 1432-119X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Overexpression of the extracellular metalloproteinase inhibitor TIMP‐4 in estrogen receptor‐negative breast cancers was found recently to be associated with a poor prognosis for survival. To pursue exploration of the theranostic applications of TIMP‐4, specific antibodies with favorable
Tissue inhibitors of metalloproteinases (TIMPs) inhibit the extracellular matrix (ECM) metalloproteinases (MMPs). To determine the source of TlMPs in synovial fluids of patients with osteoarthritis (OA), the ability of chondrocytes to express TIMP-2 and its regulation by agents found in inflammed jo
## Abstract Previous studies on tumor‐cell glycosylation mutants and drugs which inhibit oligosaccharide processing suggest that expression of sialylated and highly branched complex‐type N‐linked oligosaccharides is required for efficient tumor‐cell metastasis. These observations prompted the prese
Cholangiocarcinomas (CCAs) are aggressive cancers, with high mortality and poor survival rates. Only radical surgery offers patients some hope of cure; however, most patients are not surgical candidates because of late diagnosis secondary to relatively poor accuracy of diagnostic means. MicroRNAs (m